# Peripheral Vascular Device Market > Peripheral Vascular Device Market Research Report By Device Type (Stents, Catheters, Endografts, Atherectomy Devices, Stent-Grafts), By Application (Coronary Artery Disease, Peripheral Arterial Disease, Venous Thromboembolism, Renal Artery Disease, Carotid Artery Disease), By Material (Metallic, Biodegradable, Polymer-Based, Nitinol-Based, Platinum-Based), By Modality (Invasive, Minimally Invasive, Non-Invasive) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 4.52% - **2024:** $ 23.99 Billion - **2025:** $ 25.08 Billion - **2035:** $ 39.02 Billion - **Key Players:** Medtronic(US), Boston Scientific (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Cook Medical (US), Cardinal Health (US), Johnson & Johnson (US), Philips (NL) **Report ID:** MRFR/HC/28443-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/peripheral-vascular-device-market-30187 --- ## Market Summary ## **Peripheral Vascular Device Market Overview** As per MRFR analysis, the Peripheral Vascular Device Market Size was estimated at 23.99 (USD Billion) in 2024. The Peripheral Vascular Device Market Industry is expected to grow from 25.08 (USD Billion) in 2025 to 37.34 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 4.52% during the forecast period (2025 - 2034). ### **Key Peripheral Vascular Device Market Trends Highlighted** The Peripheral Vascular Device Market is witnessing a surge in demand due to the increasing prevalence of peripheral artery disease (PAD). The aging population and the rise in lifestyle-related diseases, such as diabetes and cardiovascular disorders, are driving the market growth. Technological advancements, such as the development of minimally invasive devices, are further contributing to the market expansion.Opportunities lie in untapped emerging markets, where the growing healthcare infrastructure and rising disposable incomes are expected to boost demand. Additionally, the focus on developing personalized and remote patient monitoring devices is creating new avenues for market growth.Recent trends include the adoption of robotic-assisted surgical procedures, which offer enhanced precision and efficiency. The integration of artificial intelligence (AI) and machine learning (ML) technologies is also gaining traction, aiding in more tailored and effective patient care. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Peripheral Vascular Device Market Drivers** ### **Increasing Prevalence of Peripheral Artery Disease** Peripheral artery disease (PAD) is a common condition that affects millions of people worldwide. It occurs when the arteries in the legs or arms become narrowed or blocked, reducing blood flow to the affected limbs. PAD can cause a variety of symptoms, including pain, numbness, and weakness in the legs or arms. In severe cases, PAD can lead to amputation. The increasing prevalence of PAD is a major driver of growth in the global peripheral vascular device market.As the population ages, the risk of developing PAD increases. Additionally, the increasing prevalence of obesity, diabetes, and smoking are also contributing to the rise in PAD cases. This is leading to a growing demand for peripheral vascular devices, such as stents, angioplasty balloons, and atherectomy devices, which are used to treat PAD. ### **Technological Advancements** Technological advancements are another major driver of growth in the global peripheral vascular device market. In recent years, there have been significant advances in the development of new and improved peripheral vascular devices. These advancements have led to the development of devices that are more effective, less invasive, and easier to use. For example, the development of drug-eluting stents has improved the long-term patency of stents and reduced the risk of restenosis.Additionally, the development of new imaging technologies has made it possible to more accurately diagnose and treat peripheral vascular disease. These technological advancements are expected to continue to drive growth in the global peripheral vascular device market in the coming years. ### **Rising Healthcare Expenditure** Rising healthcare expenditure is another factor that is driving growth in the global peripheral vascular device market. As healthcare costs continue to rise, governments and private insurers are looking for ways to reduce costs. Peripheral vascular devices can help to reduce healthcare costs by reducing the need for hospitalizations and surgeries. For example, stents can be used to treat peripheral artery disease without the need for open surgery.This can lead to significant savings in healthcare costs. Additionally, peripheral vascular devices can help to improve the quality of life for patients with peripheral vascular disease. This can lead to increased productivity and reduced absenteeism from work, which can also save money for employers. ## **Peripheral Vascular Device Market Segment Insights** ### **Peripheral Vascular Device Market Device Type Insights** The Global Peripheral Vascular Device Market is segmented into Stents, Catheters, Endografts, Atherectomy Devices, and Stent-Grafts based on Device Type. Stents are expected to dominate the market with a share of over 35% in 2023, owing to their widespread usage in treating peripheral artery disease. The increasing prevalence of cardiovascular diseases is driving the demand for stents. Additionally, technological advancements, such as the development of drug-eluting stents, are further fueling the market growth. Catheters are another major segment, accounting for a significant share of the market.They are used for diagnostic and therapeutic procedures, such as angioplasty and atherectomy.  The rising number of minimally invasive procedures is contributing to the growth of the catheter segment. Endografts are used to repair damaged blood vessels and are gaining popularity due to their ability to provide a less invasive alternative to open surgery. The increasing incidence of aortic aneurysms is expected to drive the growth of the endograft segment. Atherectomy devices are used to remove plaque from arteries and are expected to witness steady growth over the forecast period.The increasing emphasis on preventive care and the growing awareness of cardiovascular diseases are contributing to the growth of the atherectomy devices segment. Stent grafts are used to treat complex vascular conditions and offer advantages such as reduced invasiveness and shorter recovery times. The increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures are the key factors driving the market growth. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Peripheral Vascular Device Market Application Insights** The Global Peripheral Vascular Device Market is segmented into several applications, including Coronary Artery Disease, Peripheral Arterial Disease, Venous Thromboembolism, Renal Artery Disease, and Carotid Artery Disease. Coronary Artery Disease (CAD) is a condition in which the arteries that supply blood to the heart become narrowed or blocked. Peripheral Arterial Disease (PAD) is a condition in which the arteries that supply blood to the limbs become narrowed or blocked. Venous Thromboembolism (VTE) is a condition in which blood clots form in the veins.Renal Artery Disease (RAD) is a condition in which the arteries that supply blood to the kidneys become narrowed or blocked. Carotid Artery Disease (CAD) is a condition in which the arteries that supply blood to the brain become narrowed or blocked. The Global Peripheral Vascular Device Market for CAD is expected to reach USD 12.4 billion by 2024, growing at a CAGR of 4.5%. The market for PAD is expected to reach USD 6.5 billion by 2024, growing at a CAGR of 5.2%. The market for VTE is expected to reach USD 4.8 billion by 2024, growing at a CAGR of 6.1%.The market for RAD is expected to reach USD 2.7 billion by 2024, growing at a CAGR of 4.9%. The market for CAD is expected to reach USD 2.3 billion by 2024, growing at a CAGR of 4.7%. The growth of the Global Peripheral Vascular Device Market is being driven by the increasing prevalence of cardiovascular diseases, the growing demand for minimally invasive procedures, and the technological advancements in peripheral vascular devices. ### **Peripheral Vascular Device Market Material Insights** The Global Peripheral Vascular Device Market is segmented based on Material into Metallic, Biodegradable, Polymer-Based, Nitinol-Based, and Platinum-Based. Among these segments, the Metallic segment held the largest market share in 2023 and is expected to continue its dominance throughout the forecast period. The growth of this segment can be attributed to the high strength and durability of metallic materials, which make them suitable for use in demanding applications such as stents and grafts. Moreover, the increasing prevalence of peripheral artery disease and the rising number of minimally invasive procedures are expected to drive the growth of the Metallic segment in the coming years.The Biodegradable segment is expected to witness the fastest growth during the forecast period. The increasing demand for bioresorbable devices, which offer advantages such as reduced risk of infection and restenosis, is driving the growth of this segment. Additionally, ongoing advancements in biomaterial technology are expected to further contribute to the growth of the Biodegradable segment in the coming years. The Polymer-Based segment is expected to hold a significant market share during the forecast period. The versatility and low cost of polymer-based materials make them suitable for a wide range of applications in peripheral vascular devices.The increasing demand for polymer-based coatings and drug-eluting devices is expected to drive the growth of this segment in the coming years. The Nitinol-Based segment is expected to witness steady growth during the forecast period. The unique properties of Nitinol, such as its high strength, flexibility, and biocompatibility, make it a suitable material for use in peripheral vascular devices. The increasing demand for Nitinol-based stents and grafts is expected to drive the growth of this segment in the coming years. The Platinum-Based segment is expected to hold a niche market share during the forecast period.The high cost of platinum-based materials limits their widespread adoption in peripheral vascular devices. However, the excellent biocompatibility and corrosion resistance of platinum makes it a suitable material for use in high-performance devices such as pacemakers and implantable cardioverter-defibrillators (ICDs). ### **Peripheral Vascular Device Market Modality Insights** The Global Peripheral Vascular Device Market is segmented by Modality into Invasive, Minimally Invasive, and Non-Invasive. Among these, the Minimally Invasive segment held the largest market share of 42.3% in 2023 and is expected to maintain its dominance throughout the forecast period. The growth of this segment can be attributed to the increasing adoption of minimally invasive procedures, such as endovascular interventions, which offer less pain, reduced recovery time, and improved patient outcomes compared to traditional open surgeries. Furthermore, the rising prevalence of peripheral artery disease and the increasing number of minimally invasive procedures performed for the treatment of cardiovascular diseases are driving the growth of the Minimally Invasive segment.The Invasive segment is expected to witness a steady growth rate during the forecast period due to the continued use of open surgeries for complex cases and the availability of advanced surgical techniques. The Non-Invasive segment is also expected to experience significant growth owing to the increasing adoption of non-invasive imaging techniques, such as ultrasound and magnetic resonance imaging (MRI), for the diagnosis and monitoring of peripheral vascular diseases. ### **Peripheral Vascular Device Market Regional Insights** The Global Peripheral Vascular Device Market is segmented into North America, Europe, APAC, South America, and MEA. North America is expected to hold the largest market share in 2023 due to the increasing prevalence of peripheral artery disease and the presence of major market players. Europe is expected to be the second-largest market, followed by APAC. The APAC region is expected to witness significant growth due to the rising geriatric population and the increasing adoption of minimally invasive procedures. South America and MEA are expected to have a relatively smaller market share but are expected to grow at a steady pace due to the growing awareness of peripheral vascular diseases and the increasing availability of advanced healthcare infrastructure. **** Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Peripheral Vascular Device Market Key Players And Competitive Insights** Major players in the Peripheral Vascular Device Market industry are continuously engaged in developing new products and technologies to cater to the evolving needs of patients and healthcare professionals. Leading Peripheral Vascular Device Market players are investing heavily in research and development to stay competitive in the market and gain market share. The Peripheral Vascular Device Market development is also being driven by the increasing prevalence of peripheral vascular diseases and the growing demand for minimally invasive procedures. The competitive landscape of the Peripheral Vascular Device Market industry is expected to remain highly competitive in the coming years, with major players focusing on innovation, expanding their product portfolios, and strengthening their distribution networks. Medtronic plc is a leading global medical technology company that offers a wide range of Peripheral Vascular Device Market products and solutions. The company's Peripheral Vascular Device Market business unit offers a comprehensive portfolio of products for the treatment of peripheral vascular diseases, including stents, grafts, balloons, and catheters. Medtronic plc has a strong global presence and a well-established distribution network, which enables it to reach a wide range of customers. The company is also committed to innovation and has a strong track record of developing new products and technologies.Boston Scientific Corporation is another major player in the Peripheral Vascular Device Market industry. The company offers a broad range of Peripheral Vascular Device Market products and solutions for the treatment of peripheral vascular diseases, including stents, grafts, balloons, and catheters. Boston Scientific Corporation has a strong global presence and a well-established distribution network, which enables it to reach a wide range of customers. The company is also committed to innovation and has a strong track record of developing new products and technologies. ### **Key Companies in the Peripheral Vascular Device Market Include** - [Philips Healthcare](https://www.usa.philips.com/healthcare/procedure/peripheral-arterial) - LeMaitre - Braun - Siemens Healthcare - BD - Baxter International - Abbott Vascular - Cardinal Health - Boston Scientific - Stryker - Johnson Johnson (Ethicon) - Cook Medical - Medtronic - Terumo Medical Corporation - AngioDynamics ## Peripheral Vascular Device Industry Developments - **Q2 2024: MicroVention Launches LVIS EVO Intraluminal Support Device in the U.S.** MicroVention, a division of Terumo, officially launched its LVIS EVO intraluminal support device in the United States in June 2024. The new stent is designed to provide advanced intraluminal support for complex vascular conditions. ## **Peripheral Vascular Device Market Segmentation Insights** ### **Peripheral Vascular Device Market Device Type Outlook** - Stents - Catheters - Endografts - Atherectomy Devices - Stent-Grafts ### **Peripheral Vascular Device Market Application Outlook** - Coronary Artery Disease - Peripheral Arterial Disease - Venous Thromboembolism - Renal Artery Disease - Carotid Artery Disease ### **Peripheral Vascular Device Market Material Outlook** - Metallic - Biodegradable - Polymer-Based - Nitinol-Based - Platinum-Based ### **Peripheral Vascular Device Market Modality Outlook** - Invasive - Minimally Invasive - Non-Invasive ### **Peripheral Vascular Device Market Regional Outlook** - North America - Europe - South America - Asia Pacific - Middle East and Africa ## Market Drivers ### Aging Population and Lifestyle Changes The demographic shift towards an aging population, coupled with lifestyle changes, is a significant driver for the Peripheral Vascular Device Market. As individuals age, the risk of developing vascular diseases increases, leading to a higher demand for effective treatment options. Additionally, lifestyle factors such as obesity, sedentary behavior, and smoking contribute to the rising incidence of peripheral vascular conditions. Data indicates that the number of individuals aged 65 and older is expected to double by 2050, further amplifying the need for peripheral vascular devices. This demographic trend presents a substantial opportunity for manufacturers to innovate and expand their product offerings to cater to this growing patient population. ### Technological Innovations in Device Design Technological advancements play a crucial role in shaping the Peripheral Vascular Device Market. Innovations such as drug-eluting stents, bioresorbable scaffolds, and advanced imaging techniques are enhancing the efficacy and safety of vascular interventions. The introduction of these cutting-edge technologies is expected to improve patient outcomes and reduce complications associated with traditional devices. Market data indicates that the segment of drug-eluting devices is anticipated to witness substantial growth, driven by their ability to minimize restenosis rates. As manufacturers continue to invest in research and development, the market is likely to see a surge in novel devices that cater to the evolving needs of healthcare professionals and patients alike. ### Regulatory Support and Reimbursement Policies Regulatory support and favorable reimbursement policies are pivotal in shaping the Peripheral Vascular Device Market. Governments and regulatory bodies are increasingly recognizing the importance of peripheral vascular devices in improving patient outcomes. As a result, there is a trend towards streamlined approval processes for innovative devices, which can facilitate quicker market entry. Furthermore, reimbursement policies that cover these devices are essential for encouraging their adoption among healthcare providers. Market data suggests that regions with supportive reimbursement frameworks are likely to experience higher growth rates in device utilization. This regulatory environment not only fosters innovation but also enhances accessibility for patients, thereby driving overall market expansion. ### Rising Incidence of Peripheral Vascular Diseases The increasing prevalence of peripheral vascular diseases (PVD) is a primary driver for the Peripheral Vascular Device Market. Conditions such as atherosclerosis and peripheral artery disease are becoming more common, particularly among aging populations. According to recent data, the incidence of PVD is projected to rise significantly, with estimates suggesting that by 2025, nearly 20% of individuals over the age of 65 may be affected. This growing patient population necessitates the development and adoption of advanced peripheral vascular devices, as healthcare providers seek effective solutions to manage these conditions. Consequently, the demand for innovative devices, including stents and balloons, is likely to escalate, thereby propelling market growth. ### Increasing Demand for Minimally Invasive Procedures The shift towards minimally invasive procedures is significantly influencing the Peripheral Vascular Device Market. Patients and healthcare providers alike are increasingly favoring these techniques due to their associated benefits, such as reduced recovery times and lower complication rates. As a result, there is a growing demand for devices that facilitate these procedures, including catheter-based interventions and endovascular stents. Market analysis suggests that the minimally invasive segment is expected to expand rapidly, with a projected compound annual growth rate (CAGR) of over 8% in the coming years. This trend is likely to drive innovation and competition among manufacturers, as they strive to develop devices that meet the specific requirements of minimally invasive techniques. ## Future Outlook The Peripheral Vascular Device Market is projected to grow at a 4.52% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of vascular diseases, and rising healthcare expenditures. **New opportunities:** - Development of minimally invasive surgical devices for outpatient procedures. - - Expansion into emerging markets with tailored product offerings. - Integration of AI-driven analytics for personalized patient care solutions. By 2035, the market is expected to achieve robust growth, positioning itself as a leader in vascular health solutions. ## Segment Insights ### By Device Type: Stents (Largest) vs. Catheters (Fastest-Growing) In the Peripheral Vascular Device Market, stents dominate with the largest market share, representing a significant portion of the total demand. Their popularity is driven by widespread applications in treating vascular diseases, making them a staple in vascular interventions. The catheter segment, however, is rapidly gaining traction, emerging as the fastest-growing category. This is due to the increasing number of minimally invasive procedures and advancements in catheter technologies, enabling more effective treatments for peripheral vascular diseases. Stents (Dominant) vs. Catheters (Emerging) Stents are recognized as the dominant segment in the Peripheral Vascular Device Market, primarily employed to treat arterial blockages effectively. Their established role in clinical practice has made them the go-to solution for physicians, leading to their extensive use across various applications. In contrast, catheters represent an emerging segment characterized by innovation and versatility. With advancements in materials and technology, catheters are being utilized more frequently in diagnostic and therapeutic procedures. Their flexibility and ease of use are driving their growth, providing a viable alternative to traditional surgical methods, and positioning them for increased adoption in the healthcare sector. ### By Application: Peripheral Arterial Disease (Largest) vs. Venous Thromboembolism (Fastest-Growing) In the Peripheral Vascular Device Market, Peripheral Arterial Disease (PAD) commands the largest share, reflecting its significant prevalence and the rising demand for effective treatment options. This segment has been driven by the increasing incidence of lifestyle-related diseases and an aging population, which directly contributes to the demand for vascular interventions. In contrast, Venous Thromboembolism (VTE) represents the fastest-growing application in this segment, fueled by heightened awareness of the condition and advancements in catheter-based devices that facilitate treatment and prevention. Peripheral Arterial Disease (Dominant) vs. Venous Thromboembolism (Emerging) Peripheral Arterial Disease (PAD) remains a dominant player within the Peripheral Vascular Device Market, largely due to the high prevalence of atherosclerosis and the importance of effective intervention strategies. The growing number of patients requiring angioplasty and stenting adds to PAD's market strength. On the other hand, Venous Thromboembolism (VTE) is emerging rapidly, bolstered by innovations in device technology and a shift towards preventive healthcare measures. The increasing recognition of VTE's potential complications is driving investment in research and development, highlighting a trend toward more efficient and less invasive treatment options. ### By Material: Metallic (Largest) vs. Biodegradable (Fastest-Growing) The Peripheral Vascular Device Market showcases a varied distribution in its material segments, with Metallic materials commanding the largest share. This dominance is due to the established reliability and performance of metallic devices, particularly stainless steel and cobalt-chromium alloys, which are preferred for their durability and effectiveness in treatment. In contrast, the Biodegradable segment is rapidly gaining traction, driven by increasing demand for environmentally friendly solutions and improved patient outcomes post-device removal. Metallic (Dominant) vs. Biodegradable (Emerging) Metallic materials in the Peripheral Vascular Device Market, primarily consisting of stainless steel and cobalt alloys, remain dominant due to their proven strength, and compatibility with various vascular applications. These devices are favored for their robust mechanical properties, making them suitable for permanent implants. On the other hand, Biodegradable materials present an emerging trend, gaining attention for their ability to dissolve after fulfilling their purpose, thus reducing the need for additional procedures. The advancement in polymer science has led to enhanced performance in biodegradable devices, aligning with the trend towards sustainable healthcare solutions. ### By Modality: Minimally Invasive (Largest) vs. Invasive (Fastest-Growing) The Peripheral Vascular Device Market showcases a diverse range of modalities, including Invasive, Minimally Invasive, and Non-Invasive devices. Among these, the Minimally Invasive segment holds the largest market share, appealing to healthcare providers and patients for its benefits like reduced recovery times and lower risk of complications. In contrast, the Invasive segment has been gaining traction rapidly due to advancements in technology and increased adoption rates, making it the fastest-growing modality in the sector. As medical technology evolves, the growth trend in the Peripheral Vascular Device Market indicates a shift towards enhanced surgical methods, which is driving the popularity of Minimally Invasive techniques. Factors such as rising prevalence of peripheral vascular diseases, an aging population, and increased awareness about treatment options contribute to a robust growth forecast for this segment. Consequently, both Minimally Invasive and Invasive modalities are poised for positive developments, reflecting a dynamic market landscape. Modality: Minimally Invasive (Dominant) vs. Invasive (Emerging) The Minimally Invasive modality is currently the dominant player in the Peripheral Vascular Device Market, characterized by a range of procedures that involve minimal incisions and reduced hospital stays. These techniques are preferred for their benefits in enhancing patient recovery experiences while maintaining effective therapeutic outcomes. Key devices in this category include angioplasty catheters and stents, which are increasingly utilized due to their efficiency and safety. The Invasive modality, though emerging, is not to be overlooked, as it encompasses techniques that, while more traditional, offer unique advantages in specific medical scenarios. These procedures often involve direct access to the vascular system, allowing for extensive treatment options. The integration of innovative technologies and methods is enabling the Invasive segment to evolve, making it an attractive option for both healthcare providers and patients looking for robust treatment modalities. ## Regional Market Share Analysis ### North America : Market Leader in Innovation North America is the largest market for peripheral vascular devices, accounting for approximately 45% of the global market share. The region's growth is driven by an aging population, increasing prevalence of vascular diseases, and advancements in medical technology. Regulatory support from agencies like the FDA has also catalyzed innovation and market entry for new devices, enhancing patient care and outcomes. The United States is the primary contributor to this market, with key players such as Medtronic, Boston Scientific, and Abbott Laboratories leading the competitive landscape. The presence of advanced healthcare infrastructure and significant investment in R&D further solidifies North America's position. The market is characterized by rapid technological advancements and a focus on minimally invasive procedures, which are gaining traction among healthcare providers. ### Europe : Emerging Regulatory Frameworks Europe is the second-largest market for peripheral vascular devices, holding around 30% of the global market share. The region is experiencing growth due to increasing awareness of vascular diseases, a rise in geriatric populations, and supportive regulatory frameworks. The European Medicines Agency (EMA) has been instrumental in streamlining the approval processes for innovative devices, fostering a conducive environment for market expansion. Leading countries in this region include Germany, France, and the UK, where major players like B. Braun Melsungen AG and Philips are actively involved. The competitive landscape is marked by collaborations and partnerships aimed at enhancing product offerings. The focus on patient-centric solutions and technological advancements is driving the market forward, making Europe a key player in The Peripheral Vascular Device Market. ### Asia-Pacific : Rapid Growth Potential Asia-Pacific is witnessing rapid growth in the peripheral vascular device market, accounting for approximately 20% of the global share. The region's expansion is fueled by increasing healthcare expenditure, rising awareness of vascular diseases, and a growing population. Countries like China and India are leading this growth, supported by government initiatives aimed at improving healthcare infrastructure and access to advanced medical technologies. China is the largest market in the region, with significant contributions from local manufacturers and international players like Terumo Corporation and Cook Medical. The competitive landscape is evolving, with a focus on affordability and accessibility of devices. As healthcare systems in these countries continue to develop, the demand for innovative and effective peripheral vascular solutions is expected to rise, positioning Asia-Pacific as a key market in the coming years. ### Middle East and Africa : Untapped Market Opportunities The Middle East and Africa region is gradually emerging in the peripheral vascular device market, holding about 5% of the global share. The growth is driven by increasing investments in healthcare infrastructure, rising prevalence of chronic diseases, and a growing focus on improving healthcare access. Governments are implementing policies to enhance healthcare services, which is expected to boost the demand for advanced medical devices in the region. Countries like South Africa and the UAE are leading the market, with a growing presence of international players. The competitive landscape is characterized by partnerships and collaborations aimed at enhancing product availability. As healthcare systems evolve, the demand for peripheral vascular devices is anticipated to grow, presenting significant opportunities for market players in this region. ## Competitive Benchmarking The Peripheral Vascular Device Market is characterized by a dynamic competitive landscape, driven by technological advancements, increasing prevalence of vascular diseases, and a growing aging population. Major players such as Medtronic (US), Boston Scientific (US), and Abbott Laboratories (US) are strategically positioned to leverage innovation and expand their market presence. Medtronic (US) focuses on enhancing its product portfolio through continuous innovation, while Boston Scientific (US) emphasizes strategic partnerships to bolster its research and development capabilities. Abbott Laboratories (US) is actively pursuing regional expansion, particularly in emerging markets, which collectively shapes a competitive environment that is increasingly reliant on technological differentiation and strategic collaborations.Key business tactics within the Peripheral Vascular Device Market include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several key players exerting significant influence. This fragmentation allows for a diverse range of products and innovations, yet the collective strength of major companies like Medtronic (US) and Boston Scientific (US) suggests a competitive dynamic that is both collaborative and competitive, as these firms seek to establish leadership through innovation and market penetration. In August Medtronic (US) announced the launch of its next-generation drug-coated balloon technology, which is designed to improve patient outcomes in peripheral artery disease. This strategic move not only reinforces Medtronic's commitment to innovation but also positions the company to capture a larger share of the growing market for minimally invasive vascular interventions. The introduction of this technology is likely to enhance Medtronic's competitive edge by addressing unmet clinical needs and improving procedural efficiencies. In September Boston Scientific (US) entered into a partnership with a leading [digital health](https://www.marketresearchfuture.com/reports/digital-healthcare-market-7636) company to integrate artificial intelligence into its vascular device offerings. This collaboration aims to enhance patient monitoring and outcomes through data-driven insights. By embracing AI, Boston Scientific (US) is not only enhancing its product capabilities but also aligning itself with the broader trend of digital transformation in healthcare, which could significantly improve its market positioning. In July Abbott Laboratories (US) expanded its manufacturing capabilities in Asia to meet the rising demand for peripheral vascular devices in the region. This strategic expansion is indicative of Abbott's focus on regional growth and its commitment to ensuring supply chain reliability. By localizing production, Abbott is likely to reduce lead times and costs, thereby enhancing its competitive stance in a rapidly evolving market. As of October the Peripheral Vascular Device Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence, which are redefining competitive dynamics. Strategic alliances are increasingly shaping the landscape, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is expected to evolve from traditional price-based competition to a focus on technological advancements, innovative solutions, and robust supply chain management, underscoring the importance of adaptability in a rapidly changing market. ## Recent News & Developments - **Q2 2024: MicroVention Launches LVIS EVO Intraluminal Support Device in the U.S.** MicroVention, a division of Terumo, officially launched its LVIS EVO intraluminal support device in the United States in June 2024. The new stent is designed to provide advanced intraluminal support for complex vascular conditions. ## Report Scope | MARKET SIZE 2024 | 23.99(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 25.08(USD Billion) | | MARKET SIZE 2035 | 39.02(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.52% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Cook Medical (US), Cardinal Health (US), Johnson & Johnson (US), Philips (NL) | | Segments Covered | Device Type, Application, Material, Modality, Regional | | Key Market Opportunities | Integration of advanced imaging technologies enhances procedural accuracy in the Peripheral Vascular Device Market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the Peripheral Vascular Device Market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the projected market valuation for the Peripheral Vascular Device Market in 2035?** A: The projected market valuation for the Peripheral Vascular Device Market in 2035 is 39.02 USD Billion. **Q: What was the overall market valuation for the Peripheral Vascular Device Market in 2024?** A: The overall market valuation for the Peripheral Vascular Device Market in 2024 was 23.99 USD Billion. **Q: What is the expected CAGR for the Peripheral Vascular Device Market during the forecast period 2025 - 2035?** A: The expected CAGR for the Peripheral Vascular Device Market during the forecast period 2025 - 2035 is 4.52%. **Q: Which companies are considered key players in the Peripheral Vascular Device Market?** A: Key players in the Peripheral Vascular Device Market include Medtronic, Boston Scientific, Abbott Laboratories, and others. **Q: What are the projected valuations for Stents in the Peripheral Vascular Device Market by 2035?** A: The projected valuation for Stents in the Peripheral Vascular Device Market by 2035 is expected to reach between 8.0 and 11.0 USD Billion. **Q: How does the market for Catheters compare to that of Endografts in 2035?** A: By 2035, the market for Catheters is projected to be valued between 9.0 and 12.0 USD Billion, whereas Endografts may reach between 6.0 and 8.0 USD Billion. **Q: What is the anticipated market size for Peripheral Arterial Disease applications by 2035?** A: The anticipated market size for Peripheral Arterial Disease applications by 2035 is projected to be between 9.5 and 12.0 USD Billion. **Q: What materials are expected to dominate the Peripheral Vascular Device Market by 2035?** A: By 2035, Metallic and Nitinol-Based materials are expected to dominate the Peripheral Vascular Device Market, with valuations of 12.0 and 8.0 USD Billion, respectively. **Q: What is the projected market size for Minimally Invasive modalities in 2035?** A: The projected market size for Minimally Invasive modalities in 2035 is expected to be between 16.0 and 20.0 USD Billion. **Q: How does the market for Venous Thromboembolism applications compare to that of Carotid Artery Disease by 2035?** A: By 2035, the market for Venous Thromboembolism applications is projected to be valued between 6.0 and 8.0 USD Billion, while Carotid Artery Disease may reach between 10.0 and 12.0 USD Billion. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/peripheral-vascular-device-market-30187*